| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Oct―10 |
Hyperbaric Oxygen Therapy as an Immunomodulatory Intervention in COVID-19-induced ARDS: Exploring Clinical Outcomes and Transcriptomic Signatures in a Randomised Controlled Trial |
Anders Kjellberg, Allan Zhao, Anna Lussier, Adrian Hassler, Sarah Al-Ezerjawi, Emil Boström, Sergiu-Bogdan Catrina, Peter Bergman, Kenny Alexandra Rodriguez-Wallberg, Peter Lindholm |
| 2 |
[GO] |
2023―Mar―27 |
Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study |
Gilberto DeNucci, Tom Wilkinson, Carlos Sverdloff, Tainah Babadopulos, Ashley Woodcock, Jan Shute, Pedro Renato Guazelli, Federico Gerbasse, Paulo A.S. Mourão, Dave Singh, Frank M.P. van Haren, Clive Page |
| 3 |
[GO] |
2023―Jan―10 |
Establishment of multicenter COVID-19 therapeutics preclinical test system in Republic of Korea |
Hyuna Noh, Suhyeon Yoon, Sung-Hee Kim, Jiseon Kim, Jung Seon Seo, Jeong Jin Kim, In Ho Park, Jooyeon Oh, Joon-Yong Bae, Gee Eun Lee, Sun-Je Woo, Sun-Min Seo, Na-Won Kim, Youn Woo Lee, Hui Jeong Jang, Seung-Min Hong, Se-Hee An, Kwang-Soo Lyoo, Minjoo Yeom, Hanbyeul Lee, Bud Jung, Sun-Woo Yoon, Jung-Ah Kang, Sang-Hyuk Seok, Yu Jin Lee, Seo Yeon Kim, Young Been Kim, Ji-Yeon Hwang, Dain On, Soo-Yeon Lim, Sol Pin Kim, Ji Yun Jang, Ho Lee, Kyoungmi Kim, Hyo-Jung Lee, Hong Bin Kim, Sun Bean Kim, Jun Won Park, Dae Gwin Jeong, Daesub Song, Kang-Seuk Choi, Ho-Young Lee, Yang-Kyu Choi, Jung-ah Choi, Manki Song, Man-Seong Park, Jun-Young Seo, Jeon-Soo Shin, Jun-Won Yun, Ki Taek Nam, Je Kyung Seong |
| 4 |
[GO] |
2023―Jan―02 |
Patients with moderate to severe COVID-19 outcomes on remdesivir according to baseline 4C mortality score |
Jacob Sellers, Jongwha Chang, Jessica Jones, Trager D. Hintze |
| 5 |
[GO] |
2022―Oct―18 |
Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality |
Anmar AL-Taie, Ayşe Şeyma Büyük, Semra Sardas |
| 6 |
[GO] |
2021―Dec―18 |
Effects of corticosteroids on Covid-19 patients: A systematic review and meta-analysis on clinical outcomes |
Faegheh Ebrahimi Chaharom, Leili Pourafkari, Ali Asghar Ebrahimi Chaharom, Nader D. Nader |
| 7 |
[GO] |
2021―Dec―17 |
Preliminary study regarding the predicted body weight-based dexamethasone therapy in patients with COVID-19 pneumonia |
Yuri Isaka, Yasutaka Hirasawa, Jiro Terada, Yu Shionoya, Yuichiro Takeshita, Toru Kinouchi, Ken Koshikawa, Hiroshi Tajima, Taku Kinoshita, Yuji Tada, Koichiro Tatsumi, Kenji Tsushima |
| 8 |
[GO] |
2021―Oct―09 |
Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: tips for facing the second wave |
Benfante Alida, Principe Stefania, Cicero Maria Noemi, Incandela Maria, Seminara Gabriele, Durante Carmen, Scichilone Nicola |
| 9 |
[GO] |
2021―Aug―10 |
Evaluation of the Prophylactic Effect of Hydroxychloroquine on People in Close-Contact with Patients with Covid-19 |
Minoosh Shabani, Mehdi Totonchi, Omidvar Rezaeimirghaed, Latif Gachkar, Mohammadreza Hajiesmaeili, Ali Khoshkar, Mahdi Amirdosara, Ali Saffaei, Shervin Shokouhi, Masoud Mardani, Ilad Alavi Darazam, Alireza Karami, Milad Sharifi, Mana Zaman, Elham Abedheydari, Zahra Sahraei |
| 10 |
[GO] |
2021―Jul―13 |
Fibrinolytic or anti-plasmin (nafamostat) therapy for COVID-19: a timing challenge for clinicians |
Hong-Long Ji, Brant M. Wagener, Timothy J. Ness, Runzhen Zhao |
| 11 |
[GO] |
2021―Jun―24 |
The impact of SARS-COV2 pandemic on the management oF IPF patients: Our narrative experience |
Alida Benfante, Riccardo Messina, Ilaria Piccionello, Rosangela Di Liberti, Stefania Principe, Nicola Scichilone |
| 12 |
[GO] |
2021―Jun―12 |
Inhaled bronchodilators use and clinical course of adult inpatients with Covid-19 pneumonia in Spain: A retrospective cohort study |
Elena Villamañán, Carmen Sobrino, Carlos Carpio, Marta Moreno, Ana Arancón, Catalina Lara, Ester Pérez, Carlos Jiménez, Ester Zamarrón, Inmaculada Jiménez-Nácher, Alicia Herrero, Rodolfo Álvarez-Sala |
| 13 |
[GO] |
2021―May―21 |
Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19 |
Roman Maslennikov, Vladimir Ivashkin, Ekaterina Vasilieva, Maxim Chipurik, Polina Semikova, Victoria Semenets, Tatyana Russkova, Anna Levshina, Diana Grigoriadis, Shamil Magomedov, Irina Efremova, Natiya Dzhakhaya |
| 14 |
[GO] |
2021―Apr―30 |
Endothelin Antagonism and Sodium Glucose Co-transporter 2 Inhibition A Potential Combination Therapeutic Strategy for COVID-19 |
Marie Fisk, Magnus Althage, Sven Moosmang, Peter J. Greasley, Andrew P. Cope, David RW. Jayne, James Galloway, Frances Hall, Ian B. Wilkinson, Philip Ambery, Joseph Cheriyan |
| 15 |
[GO] |
2021―Mar―14 |
Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects |
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Naeem Qusty, Natália Cruz-Martins, Gaber El-Saber Batiha |
| 16 |
[GO] |
2021―Jan―18 |
Antihistamines and azithromycin as a treatment for COVID-19 on primary health care - A retrospective observational study in elderly patients |
Juan Ignacio Morán Blanco, Judith A. Alvarenga Bonilla, Sakae Homma, Kazuo Suzuki, Philip Fremont-Smith, Karina Villar Gómez de las Heras |
| 17 |
[GO] |
2020―Nov―28 |
Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19 |
Sugin Lal Jabaris S, Ranju V |
| 18 |
[GO] |
2020―Aug―29 |
Dual-Histamine Receptor Blockade with Cetirizine - Famotidine Reduces Pulmonary Symptoms in COVID-19 Patients |
Reed B. Hogan, Reed B. Hogan, Tim Cannon, Maria Rappai, John Studdard, Doug Paul, Thomas P. Dooley |
|
